Steroid showdown: which strategy prevents adrenal crisis after surgery?
NCT ID NCT07558135
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of managing steroid replacement after adrenalectomy (removal of an adrenal gland). One approach gives steroids to everyone right after surgery, while the other withholds them if a morning blood test shows normal cortisol levels. The goal is to see which method better prevents adrenal insufficiency, a condition where the body can't make enough stress hormones. The trial will follow 96 patients for three months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hydrocortisone
- What this could lead to
- If successful, this trial could establish a clearer, safer approach to steroid use after adrenalectomy, reducing the risk of adrenal insufficiency and life-threatening adrenal crisis.
- What could go wrong
- This is a relatively small, single-center trial that has not yet started recruiting. The results may not apply to all patients, and the best management strategy may still depend on individual factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL GLAND DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.